| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18.8B | $16.3B | $14.4B | $12.7B | $9.6B | $1.8B | $1.0B | $1.0B |
| Cost of Revenue | — | — | — | — | — | $0.3B | $0.3B | $0.2B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $2.9B | $2.8B | $2.5B | $2.3B | $1.7B | $1.4B | $1.2B | $1.2B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $4.9B | $3.6B | $3.1B | $2.6B | $2.5B | $0.5B | $-0.2B | $-0.1B |
| Net Income | $3.9B | $3.0B | $2.4B | $2.1B | $2.1B | $0.4B | $-0.0B | $0.0B |
| EPS (Basic) | $13.82 | $10.58 | $8.49 | $7.38 | $7.65 | $1.70 | $-0.17 | $0.19 |
| EPS (Diluted) | $13.67 | $10.43 | $8.42 | $7.28 | $7.56 | $1.68 | $-0.17 | $0.18 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $37.0B | $32.1B | $27.8B | $27.7B | $15.5B | $10.9B | $6.3B | $5.2B |
| Current Assets | $14.1B | $9.7B | $5.6B | $5.0B | $5.2B | $8.0B | $3.6B | $2.4B |
| Cash & Equivalents | $2.9B | $3.6B | $2.8B | $2.8B | $2.6B | $6.4B | $2.1B | $1.5B |
| Total Liabilities | $17.2B | $13.7B | $10.5B | $11.3B | $5.6B | $5.8B | $2.5B | $2.8B |
| Current Liabilities | $10.4B | $7.5B | $3.8B | $3.6B | $2.7B | $3.5B | $2.0B | $2.1B |
| Stockholders' Equity | $19.7B | $18.4B | $17.3B | $16.4B | $9.9B | $5.1B | $3.7B | $2.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6.2B | $4.9B | $5.0B | $3.9B | $3.3B | $2.4B | $2.3B | $2.1B |
| Investing Cash Flow | $-2.3B | $-0.2B | $-0.9B | $-5.4B | $-4.0B | $-0.1B | $-0.6B | $-0.5B |
| Capital Expenditures | $0.1B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.0B |
| Financing Cash Flow | $-1.5B | $-0.4B | $-4.3B | $1.7B | $-3.2B | $2.0B | $-1.0B | $-0.6B |